170 related articles for article (PubMed ID: 2431654)
1. Dicoumarol-sensitive glucuronidation of benzo(a)pyrene metabolites in rat liver microsomes.
Segura-Aguilar JE; Barreiro V; Lind C
Arch Biochem Biophys; 1986 Nov; 251(1):266-75. PubMed ID: 2431654
[TBL] [Abstract][Full Text] [Related]
2. Formation of benzo[a]pyrene-3,6-quinol mono- and diglucuronides in rat liver microsomes.
Lind C
Arch Biochem Biophys; 1985 Jul; 240(1):226-35. PubMed ID: 4015101
[TBL] [Abstract][Full Text] [Related]
3. A note on the inhibition of DT-diaphorase by dicoumarol.
Preusch PC; Siegel D; Gibson NW; Ross D
Free Radic Biol Med; 1991; 11(1):77-80. PubMed ID: 1718826
[TBL] [Abstract][Full Text] [Related]
4. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
Aiyar J; De Flora S; Wetterhahn KE
Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
[TBL] [Abstract][Full Text] [Related]
5. Hepatic low-level chemiluminescence during redox cycling of menadione and the menadione-glutathione conjugate: relation to glutathione and NAD(P)H:quinone reductase (DT-diaphorase) activity.
Wefers H; Sies H
Arch Biochem Biophys; 1983 Jul; 224(2):568-78. PubMed ID: 6191666
[TBL] [Abstract][Full Text] [Related]
6. Conversion of benzo[a]pyrene-3,6-quinone to quinol glucuronides with rat liver microsomes or purified NADPH-cytochrome c reductase and UDP-glucuronosyltransferase.
Bock KW; Lilienblum W; Pfeil H
FEBS Lett; 1980 Dec; 121(2):269-72. PubMed ID: 6780376
[No Abstract] [Full Text] [Related]
7. Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates.
Lind C; Vadi H; Ernster L
Arch Biochem Biophys; 1978 Sep; 190(1):97-108. PubMed ID: 81662
[No Abstract] [Full Text] [Related]
8. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.
Lilienblum W; Bock-Hennig BS; Bock KW
Mol Pharmacol; 1985 Apr; 27(4):451-8. PubMed ID: 3982390
[TBL] [Abstract][Full Text] [Related]
9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
10. Modulation of microsomal benzo[a]pyrene metabolism by DNA.
Keller GM; Jefcoate CR
Mol Pharmacol; 1983 May; 23(3):735-42. PubMed ID: 6306433
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
Preusch PC; Smalley DM
Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the rate of reduction of benzo(a)pyrene-3,6-quinone and the formation of benzo(a)pyrene-3,6-quinol glucuronides in rat liver microsomes.
Lind C
Biochem Pharmacol; 1985 Mar; 34(6):895-7. PubMed ID: 3977961
[No Abstract] [Full Text] [Related]
14. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
Hu Z; Wells PG
Toxicol Appl Pharmacol; 1994 Aug; 127(2):306-13. PubMed ID: 8048075
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of the metabolism and mutagenicity of benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol by naphthazarin and other naphthol derivatives.
Espino PC; Sullivan PD
Biochem Biophys Res Commun; 1987 Feb; 142(3):939-46. PubMed ID: 2435285
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes.
Tampo Y; Yonaha M
Arch Biochem Biophys; 1996 Oct; 334(1):163-74. PubMed ID: 8837752
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.
De Flora S; Bennicelli C; D'Agostini F; Izzotti A; Camoirano A
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):69-74. PubMed ID: 7534225
[TBL] [Abstract][Full Text] [Related]
18. Modulation of halobenzene-induced hepatotoxicity by DT-diaphorase modulators, butylated hydroxyanisole and dicoumarol: evidence for possible involvement of quinone metabolites in the toxicity of halobenzenes.
Mizutani T; Miyamoto Y
Toxicol Lett; 1999 Mar; 105(1):25-30. PubMed ID: 10092053
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
Joseph P; Jaiswal AK
Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Spencer CB; Rifkind AB
Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
